Stocks and Investing
Stocks and Investing
Wed, March 20, 2024
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
Gil Blum Maintained (TSHA) at Strong Buy with Increased Target to $7 on, Mar 20th, 2024
Gil Blum of Needham, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Increased Target from $5 to $7 on, Mar 20th, 2024.
Gil, nor any peers, have made any analyst calls on TSHA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources